Barbexaclone

From Wikipedia, the free encyclopedia

Barbexaclone
Systematic (IUPAC) name
(-)-N,α-Dimethylcyclohexaneethylammonium.5-ethyl-5-phenyl-barbiturate
Identifiers
CAS number 4388-82-3
ATC code N03AA04
PubChem 71196
Chemical data
Formula C22H33N3O3 
Mol. mass 387.52 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Barbexaclone (marketed in Italy as Maliasin by Abbott Laboratories) is a salt compound of phenobarbital and propylhexedrine. It was introduced in 1983. It is reported to be as effective as phenobarbital but better tolerated. 100 mg of barbexaclone is equivalent to 60 mg of phenobarbital. It is not available on prescription in Belgium, Germany, the Netherlands, the UK or the U.S.

[edit] References

  • The Treatment of Epilepsy 2nd Ed by S. D. Shorvon (Editor), David R. Fish (Editor), Emilio Perucca (Editor), W. Edwin Dodson (Editor). Published by Blackwell 2004. ISBN 0-632-06046-8


Languages